STOCKHOLM, Sept. 21, 2024 /PRNewswire/ — Ericsson (NASDAQ: ERIC) today announces that Carolina Dybeck Happe has decided to resign from its Board of Directors. Dybeck Happe has served on Ericsson’s Board since 2022.
The announcement follows the September 12 appointment of Dybeck Happe to the position of Executive Vice President and Chief Operations Officer with Microsoft.
Jan Carlson, Chair of the Board of Directors, says: “I’d like to thank Carolina for her service on our Board and for her contributions and commitment to Ericsson. Her expertise and insights are greatly appreciated and respected and I wish her all the best in her new role.”
Börje Ekholm, President and CEO of Ericsson, says: “Carolina has been a valued Board member and thoughtful contributor since joining us in 2022. Microsoft is an important partner of Ericsson and we very much look forward to working with Carolina in her new capacity. We wish her great success.”
NOTES TO EDITORS:
FOLLOW US:
Subscribe to Ericsson press releases here
Subscribe to Ericsson blog posts here
https://twitter.com/ericsson
https://www.facebook.com/ericsson
https://www.linkedin.com/company/ericsson
MORE INFORMATION AT:
Ericsson Newsroom
media.relations@ericsson.com (+46 10 719 69 92)
investor.relations@ericsson.com (+46 10 719 00 00)
ABOUT ERICSSON:
Ericsson’s high-performing networks provide connectivity for billions of people every day. For nearly 150 years, we’ve been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
|
Carolina Dybeck Happe resigns from Ericsson’s Board of Directors |

Đề xuất
Nebu Ease Portable Nebulizer Claims Evaluated: 2026 Consumer Research Report on Mesh Nebulizer Technology, Respiratory Comfort Features, and What Buyers Should Verify
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference